Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.17/2814
Registo completo
Campo DCValorIdioma
dc.contributor.authorMoreira-Rosário, A-
dc.contributor.authorPinheiro, H-
dc.contributor.authorCalhau, C-
dc.contributor.authorAzevedo, LF-
dc.date.accessioned2017-11-27T16:02:27Z-
dc.date.available2017-11-27T16:02:27Z-
dc.date.issued2016-11-10-
dc.identifier.citationBMJ Open. 2016 Nov 10;6(11):e013098.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/2814-
dc.description.abstractINTRODUCTION: Cardiovascular diseases (CVD) are the leading cause of mortality worldwide and diet is an important contributor to CVD risk. Thus, several food derivatives are being investigated for their beneficial impact on reducing cardiometabolic risk factors, either in risk groups or in healthy population as a preventive measure. Wheat germ is a food by-product with high nutritional value, especially as a concentrated source of dietary fibre and essential fatty acids, but its incorporation into the diet has been rare up to now. Previous studies do not clarify the hypothesised potential causal relationship between the consumption of wheat germ and benefits for human health. METHODS AND ANALYSIS: We are conducting a randomised, double-blinded, crossover, placebo-controlled clinical trial designed to assess the physiological effects of daily consumption of wheat germ-enriched bread (containing 6 g of wheat germ) compared with non-enriched bread, over a 4-week period with a 15-week follow-up, in a healthy human population. A total of 55 participants (healthy volunteers, aged 18-60) have been recruited from the Porto metropolitan area in northern Portugal. Our aim is to evaluate the health effects of wheat germ on blood cholesterol and triglycerides, postprandial glycaemic response, gastrointestinal function and discomfort, and changes in intestinal microbiota and insulin resistance as secondary outcomes. The study follows the best practices for evaluating health claims in food according to the European Food Safety Authority (EFSA) scientific opinion, namely random allocation, double blinding, reporting methods to measure and maximise compliance, and validated outcomes with beneficial physiological effects as recommended by EFSA. ETHICS AND DISSEMINATION: The study has been approved by the Health Ethics Committee of São João Hospital Centre (156-15) and the Ethics Committee of Faculty of Medicine of the University of Porto (PCEDCSS-FMUP07/2015). Results will be disseminated through peer-reviewed publications and presentations at international scientific meetings.pt_PT
dc.language.isoengpt_PT
dc.publisherBMJ Publishing Grouppt_PT
dc.relationUID/IC/4255/2013pt_PT
dc.relationFCOMP- 01-0202-FEDER-038861pt_PT
dc.relationPOCI-01-0145-FEDER-007746pt_PT
dc.rightsopenAccesspt_PT
dc.subjectHCC INFpt_PT
dc.subjectCardiovascular Riskpt_PT
dc.subjectGastrointestinal Discomfortpt_PT
dc.subjectHealth Claimspt_PT
dc.subjectRandomized Controlled Trialpt_PT
dc.subjectWheat Germpt_PT
dc.titleCan Wheat Germ Have a Beneficial Effect on Human Health? A Study Protocol for a Randomised Crossover Controlled Trial to Evaluate its Health Effectspt_PT
dc.typearticlept_PT
dc.peerreviewedyespt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
degois.publication.firstPagee013098pt_PT
degois.publication.issue11pt_PT
degois.publication.titleBMJ Openpt_PT
degois.publication.volume6pt_PT
dc.identifier.doi10.1136/bmjopen-2016-013098pt_PT
Aparece nas colecções:INF - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
BMJ Open 2016.pdf1,05 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.